Streptozotocin, 1982–2022: Forty Years from the FDA’s Approval to Treat Pancreatic Neuroendocrine Tumors
Capdevila, Jaume ; Ducreux, Michel ; García Carbonero, Rocio ; Grande, Enrique ; Halfdanarson, Thorvardur ; Pavel, Marianne ; Tafuto, Salvatore ; Welin, Staffan ; Valentí, Vicente ; Salazar, Ramón
Neuroendocrinology, 2022-11, Vol.112 (12), p.1155-1167 [Periódico revisado por pares]Basel, Switzerland: S. Karger AG
Texto completo disponível